Affiliation: Wyeth Research
- Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactionsMichael E Thase
Department of Psychiatry, University of Pittsburgh Medical Center, Western Psychiatric Institute and Clinic, 3811 O Hara Street, Pittsburgh, PA 15213 2593, USA
J Womens Health (Larchmt) 14:609-16. 2005..To investigate whether differences in antidepressant efficacy are moderated by an interaction of age and gender...
- Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIsCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Biol Psychiatry 63:424-34. 2008..To compare venlafaxine and selective serotonin reuptake inhibitors (SSRIs; fluoxetine, sertraline, paroxetine, fluvoxamine, and citalopram) in the treatment of depression...
- Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placeboA R Entsuah
Wyeth Ayerst Research, Collegeville, PA 19426, USA
J Clin Psychiatry 62:869-77. 2001..This investigation compared these patient subpopulations on the basis of remission and response rates associated with venlafaxine and selective serotonin reuptake inhibitor (SSRI) treatment...
- Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetineRichard Entsuah
Global Clinical Biostatistics, Wyeth Ayerst Research, 500 Arcola Road, Collegeville, PA 19426, USA
J Psychiatr Res 36:111-8. 2002..Quantifying efficacy and safety differences between drugs is difficult because rigorous statistical methods to assess benefit and risk simultaneously are lacking...
- A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorderMark Pollack
Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114 2790, USA
Psychopharmacology (Berl) 194:233-42. 2007..Few randomized, placebo-controlled trials have evaluated the comparative efficacy and tolerability of more than one pharmacological agent for panic disorder...
- A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorderNicholas A DeMartinis
University of Connecticut School of Medicine, Farmington, Conn, USA
J Clin Psychiatry 68:677-88. 2007..This study evaluated the efficacy and safety of desvenlafaxine succinate extended-release in major depressive disorder (MDD)...
- Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended releaseJames M Ferguson
University of Utah School of Medicine, Psychiatry, Salt Lake City, UT 84103, USA
J Clin Psychiatry 68:58-68. 2007..To compare the long-term efficacy of venlafaxine extended release (ER) with placebo in preventing panic disorder relapse in out-patient treatment responders...
- Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placeboCharles Shelton
University of Kentucky, Lexington, Kentucky, USA
Int Clin Psychopharmacol 20:233-8. 2005..Remission was achieved earlier with venlafaxine and lasted throughout the remainder of the study. These results demonstrate that venlafaxine XR is more effective than fluoxetine/paroxetine for sustaining remission of depressive symptoms...
- Venlafaxine versus placebo in the preventive treatment of recurrent major depressionStuart A Montgomery
Imperial College School of Medicine, PO Box 8751, London W13 8WH, England, UK
J Clin Psychiatry 65:328-36. 2004..Long-term efficacy and safety of prophylactic venlafaxine treatment were evaluated in outpatients with recurrent major depression...
- Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depressionStephen M Stahl
The Neuroscience Education Institute, Carlsbad, California 92009, USA
Biol Psychiatry 52:1166-74. 2002..The dual serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine is a dual reuptake inhibitor that may therefore offer greater efficacy than selective serotonin reuptake inhibitors (SSRIs)...
- A critical examination of the sensitivity of unidimensional subscales derived from the Hamilton Depression Rating Scale to antidepressant drug effectsRichard Entsuah
Clinical Biostatistics, Wyeth Research, 500 Arcola Road, Collegeville, PA 19426, USA
J Psychiatr Res 36:437-48. 2002..Our data further suggest the subscales can predict the presence of remission. Given these findings, prudent use of these subscales may be appropriate, cost-effective, and informative...
- A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorderMichael R Liebowitz
Department of Psychiatry, Columbia University, New York, NY, USA
J Clin Psychiatry 68:1663-72. 2007..This study evaluated the efficacy and tolerability of desvenlafaxine succinate (desvenlafaxine) in the treatment of major depressive disorder (MDD)...